Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of pravastatin to prevent preterm birth
2017-005021-21Phase 2Terminated
- Sponsor
- University of Edinburgh
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Preterm labor (PTL) and preterm birth comparing Pravastatin with Placebo (2 arms). Primary endpoint: Recruitment, retention and outcome collection feasibility. Started Aug 2018; status: terminated.
02
Drugs
pravastatin
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on 2017-005021-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005021-21.